Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting

Cellular immunotherapy, including the chimeric antigen receptor T (CAR-T) cell therapy and CAR- natural killer (CAR-NK) cell therapy, has undergone extensive clinical investigation and development in recent years. CAR-T cell therapy is now emerging as a powerful cancer therapy with enormous potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ji-nuo, Gu, Tianning, Hu, Yongxian, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508791/
https://www.ncbi.nlm.nih.gov/pubmed/36153595
http://dx.doi.org/10.1186/s40164-022-00316-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508791/
https://www.ncbi.nlm.nih.gov/pubmed/36153595
http://dx.doi.org/10.1186/s40164-022-00316-8

Ejemplares similares